D
ifferentiation of growth-arrested 3T3-L1 preadipocytes into adipocytes is induced by hormonal stimuli that trigger expression of CCAAT enhancer binding protein ␤ (C/EBP␤) (1-3) and, thereby, a transcriptional cascade that gives rise to the adipocyte phenotype. C/EBP␤ activates the expression of the genes for two pleiotropic transcription factors, C/EBP␣ and PPAR␥ (4, 5) , which in turn activate the expression of numerous adipogenic genes. Although maximal expression of C/EBP␤ occurs rapidly (within 2-4 h) on induction of differentiation and remains at this level over the next 48 h, the acquisition of DNA binding activity by C/EBP␤ required for the expression of C/EBP␣ and PPAR␥ only occurs after a long lag period of Ϸ12-14 h (1, 2, 6) . At the end of the lag period, growth-arrested preadipocytes synchronously enter the cell cycle and undergo several rounds of mitotic clonal expansion (2, 3), a process required for subsequent differentiation. It is believed that chromatin remodeling occurs during mitotic clonal expansion and is a prerequisite of terminal differentiation. Presumably, this delay prevents the premature expression of C/EBP␣, which is antimitotic, and allows mitotic clonal expansion and chromatin remodeling to occur before its expression (5, 7) .
We recently showed that C/EBP␤ must undergo sequential phosphorylation to acquire DNA binding ability (6) . Immediately after the expression of C/EBP␤, a ''priming'' phosphorylation occurs on Thr 188 catalyzed by MAP kinase, which is required but is insufficient for acquisition of DNA binding activity. After the lag period (at the G 1 3 S phase checkpoint), glycogen synthase kinase ␤ (GSK3␤) translocates from the cytoplasm into the nucleus and phosphorylates C/EBP␤ on Ser 184 or Thr 179 , giving rise to DNA binding activity (6) . These and other findings suggest that dual phosphorylation of C/EBP␤ induces a conformational change that leads to acquisition of DNA binding activity possibly by exposing the DNA binding domain.
An impediment to investigating the mechanism by which phosphorylation alters the DNA binding activity of C/EBP␤ is the complexity of the mixture of leucine zipper proteins in nuclear extracts of 3T3-L1 cells. This mixture includes several C/EBP family members that are capable of forming homo-and heterodimers, including three C/EBP␤ isoforms [i.e., flC/EBP␤ (Ϸ39 kDa), C/EBP␤/liver activating protein (LAP) (Ϸ38 kDa), and dominantnegative C/EBP␤/liver inhibiting protein (LIP) (Ϸ18 kDa)] (8); C/EBP␦ (9, 10); and dominant-negative CHOP-10 (11). All of these factors are found in nuclear extract of 3T3-L1 cells after the induction of differentiation. Because these leucine zipper transcription factors can homo-and heterodimerize (12) , interpretation of binding data with nuclear extracts becomes difficult. To circumvent these difficulties, the present investigation used purified rC/EBP␤/ LAP to evaluate the effects of phosphorylation and -SS-bondinduced dimerization on the DNA binding activity and transactivation capacity. Our findings indicate that the dual phosphorylation of C/EBP␤/LAP leads to a conformational change that facilitates dimerization, rendering the DNA binding domain accessible to the C/EBP regulatory element in DNA.
Results and Discussion
Recombinant C/EBP␤/LAP Is Phosphorylated by MAPK and GSK3␤.
GST-rC/EBP␤/LAP was prepared by using an expression system that produced a substantial quantity of the protein in the native state. The protein was partially purified by GSH-agarose chromatography, followed by cleavage with PreScission protease and final purification to homogeneity by CM-Sepharose ion exchange chromatography (Fig. 1A) . The apparent molecular mass of rC/EBP␤/LAP was 34 kDa (or 35 kDa when phosphorylated by MAPK). Recombinant C/EBP␤/LAP is phosphorylated by MAPK alone and is further phosphorylated by GSK3␤, but only after a ''priming'' phosphorylation by MAPK (Fig. 1B) .
In experiments designed to fragment rC/EBP␤/LAP, we determined that cleavage by thrombin occurs at two sites, giving rise to 3-, 14-, and 17-kDa fragments. As illustrated in Fig. 1C , three protein species of 34-, 31-, and 17-kDa molecular mass were evident by protein staining of SDS/PAGE gels during the course of proteolysis (Fig. 1C) . The 31-and 14-kDa fragments were identified on SDS/PAGE gels with anti-C/EBP␤/LAP N-terminal antibody, whereas the 31-and 17-kDa fragments formed during proteolysis were identified with anti-C/EBP␤/ LAP C-terminal antibody. The N-and C-terminal epitopes of the antibodies are shown at the bottom of Fig. 1C . The phosphorylation sites (Ser 184 , Thr 179 , and Thr 188 ) are located in the C-terminal 17-kDa fragment.
DNA Binding Activity Is Increased by Dual Phosphorylation by MAPK
and GSK3␤. Recombinant C/EBP␤/LAP was phosphorylated by MAPK and/or GSK3␤ as described in Fig. 1B and then subjected to electrophoretic mobility shift assay (EMSA) with a labeled oligonucleotide corresponding to the C/EBP regulatory element in the C/EBP␣ gene promoter. Substantial DNA binding was detected with only 1 ng ¶ of rC/EBP␤/LAP after dual phosphorylation by MAPK and GSK3␤, with virtually no binding occurring in the absence of either ( Fig. 2A) . Although increasing the level of rC/EBP␤/LAP by 10-fold led to detectable DNA binding, even with either MAPK or GSK3␤ alone, dual phosphorylation of rC/EBP␤/LAP by both kinases led to a Ն100-fold in DNA binding than by either kinase alone. It should be noted that previous mass spectrometric analysis showed conclusively that dual phosphorylation by MAPK and GSK3␤ occurs at Thr 188 and either Ser 184 or Thr 179 (6) .
These findings were verified with the C/EBP regulatory elements of several other promoters of genes that are transactivated by members of the C/EBP family of transcription factors. DNA binding activities were measured with nuclear extract from 3T3-L1 cells obtained at 4 h (before acquisition of DNA binding activity) or 24 h (after acquisition of DNA binding activity) (1, 6) after the induction of differentiation (Fig. 2B ). The C/EBP regulatory elements of the C/EBP␣, aP2/422, SCD1, PPAR␥, and GLUT4 gene promoters exhibited patterns similar to that of the C/EBP␣ promoter element (i.e., stronger binding activity by 24-than by 4-h nuclear extracts). Further, as shown in Fig. 2B , rC/EBP␤/LAP exhibits DNA binding to this group of promoter elements only after dual phosphorylation by MAPK and GSK3␤.
We also determined the effect of mutating the phosphorylation site Thr and Ser residues to Glu in an attempt to constitutively mimic the effect of phosphorylation. The three phosphorylation sites, Thr 179 , Ser 184 , and Thr 188 , were mutated to Ala or Glu. In a previous report we showed that mutation of Thr 188 to Ala abolished the DNA binding response to dual phosphorylation by MAPK and GSK3␤ (6) . Doubly mutated Thr 179 /Thr 188 to Glu 179 /Glu 188 (ESE mutant) provoked increased DNA binding relative to the AAA or TSA mutations, albeit less than that of the dually phosphorylated wild-type (Wt) construct (Fig. 2C ). ESE mutant exhibited higher DNA binding activity than TEE mutant. As previously shown by LC-MS/MS analysis, C/EBP␤/LAP is dually phosphorylated on either Thr 179 /Thr 188 or Ser 184 /Thr 188 . However, the triply phosphorylated form has never been detected (6) . Therefore, of the two possible combinations of dual phosphorylation, Thr 179 /Thr 188 appears to be more effective than Thr 184 /Thr 188 in activating DNA binding. Although dual-Glu substitutions increase DNA binding, they do not achieve the activity of the dually phosphorylated form presumably because Glu mutants do not produce the optimal conformation required for maximal DNA binding activity. Taken together, however, these results show that dual phosphorylation of ¶ As quantified by comparative EMSA experiments, 1 ng of pure rC/EBP␤/LAP is equivalent to the amount of C/EBP␤/LAP present in 5 g of nuclear extract protein from 3T3-L1 cells 24 h after the induction of differentiation. C/EBP␤/LAP is required for increased binding to adipocyte genespecific promoters.
Cell-Free Transcription of Adipocyte-Specific Promoters Is Activated
by Dual Phosphorylation. Although exposure of 3T3-L1 preadipocytes to inhibitors of MAPK or GSK3␤ prevents C/EBP␤/LAPdependent processes (i.e., mitotic clonal expansion and terminal differentiation) (6), questions remain as to whether these effects are due solely to a blockade of C/EBP␤ phosphorylation. To directly assess the effect of phosphorylation of C/EBP␤/LAP on transcriptional activation, we used the cell-free transcription system used previously in our laboratory (13) . Nuclear extracts from 3T3-L1 preadipocytes or adipocytes provided the basal transcriptional machinery along with rC/EBP␤/LAP that had (or had not) been phosphorylated by MAPK and/or GSK3␤. The promoters of several adipocyte-specific genes [i.e., the C/EBP␣ (4), aP2/422 (13), and SCD1 (14) genes] were fused to a luciferase reporter and served as DNA templates. The resulting RNA transcripts were analyzed by PCR. In the absence of nuclear extract or rC/EBP␤/LAP, no PCR product was detected (Fig. 3A) , indicating the effectiveness of removal of the luciferase template with DNase1. In the presence of nuclear extract from day-2 3T3-L1 cells, transcription driven by the aP2/422 promoter was increased compared with that from day-0 cells, consistent with the fact that aP2/422 is expressed by 3T3-L1 preadipocytes 2 days after the induction of differentiation (5). To determine the effect of dual phosphorylation, rC/EBP␤/LAP was first incubated with and/or without MAPK and GSK3␤ and then with day-0 preadipocyte nuclear extract and the other components of the cell-free transcription system. As shown in Fig. 3A , transcription was activated by Ն10-fold after phosphorylation by MAPK and GSK3␤. Thus, dual phosphorylation of rC/EBP␤/ LAP (Fig. 1B) markedly increased transcription. An unrelated viral promoter (SV40-driven transcript), included as an internal control, exhibited Ϯ1.5-fold variation between the groups based on the real-time PCR (data not shown). Other adipocyte-specific promoters, including those from the C/EBP␣ or SCD1 genes, were also tested and exhibited substantially increased transcription only when rC/EBP␤/LAP was phosphorylated by both MAPK and GSK3␤ (Fig. 3B) . These findings indicate that dual phosphorylation of C/EBP␤/LAP by MAPK and GSK3␤ is not only required for DNA binding activity, but also for transcriptional activation.
Dual Phosphorylation Induces a Conformational Change That Facili-
tates Dimerization and DNA Binding. In studies with an analogous model system, McKnight's group used a short C-terminal segment of C/EBP␣ encompassing the leucine zipper and adjacent DNA binding domain. Their findings suggested that C/EBP␣ undergoes conformation-induced dimerization of the leucine zipper during the binding and release of DNA (15) . We considered the possibility that dual phosphorylation of C/EBP␤/LAP might induce a similar conformational change that facilitates dimerization through the C-terminal leucine zipper and, thereby, DNA binding (6) . To address this hypothesis, rC/EBP␤/LAP was phosphorylated and cross-linked with glutaraldehyde. As illustrated in Fig. 4A , dimer was generated within 30 sec of exposure to the cross-linking agent and was markedly facilitated by dual phosphorylation. At longer times of exposure to glutaraldehyde, rC/EBP␤/LAP formed multimers as well as dimers, which was also increased by phosphorylation. These results suggested that phosphorylation promoted the interaction between rC/EBP␤/ LAP monomers, supporting the occurrence of a conformational change. Given that rC/EBP␤/LAP exists in equilibrium between monomeric and dimeric forms, phosphorylation appeared to shift the equilibrium toward dimer, thereby promoting binding to the cognate C/EBP regulatory element. Because the use of glutaraldehyde precluded DNA binding analysis, we sought another approach to investigate the role of dimerization in DNA binding (see next paragraph).
Further evidence for a phosphorylation-induced conformational change/dimerization derives from studies in which rC/EBP␤/LAP was exposed to mild oxidizing conditions with oxidized glutathione (GSSG). It is of interest that C/EBP␤/LAP possesses five sulfhydryl groups (ϪSH), one of which is C- terminal and abuts the leucine zipper dimerization domain. Thus, this -SH group pair in the C/EBP␤/LAP homodimer might be expected to readily undergo oxidation to form an interchain disulfide bond that would stabilize the leucine zipper dimer and create a DNA binding pocket. Thus, we tested the effect of GSSG-induced oxidation of rC/EBP␤/LAP on DNA binding activity before and after dual phosphorylation. When rC/EBP␤/ LAP was exposed to GSSG, both the un-and dual-phosphorylated proteins were converted to dimers (Fig. 4B) . Of interest, however, only doubly phosphorylated rC/EBP␤/LAP exhibited DNA binding activity on dimerization. Moreover, phosphorylation status alone appeared to have little effect on dimerization caused by GSSG. The close correlation between dimerization and DNA binding activity of GSSG-treated C/EBP␤/LAP suggests that dimerization is necessary, but without phosphorylation is not sufficient to induce a conformation that will bind DNA. Rather, dual phosphorylation is necessary to induce the ''active'' conformation. Moreover, comparison of the extent of dimerization of unphosphorylated versus phosphorylated rC/EBP␤/LAP suggests that dual phosphorylation increases the extent of dimerization (Fig. 4B Upper) .
Because C/EBP␤/LAP possesses five cysteines, numerous combinations of disulfide bonds between the two monomeric molecules are possible. To minimize the number of possible combinations of cysteines involved, we took advantage of the fact that C/EBP␤/LAP can be digested with thrombin to generate Nand C-terminal halves of molecules that have two and three cysteines, respectively (Fig. 1C) . Thus, if two C/EBP␤/LAP molecules are connected through any pair of cysteinyl-SH residues, the resulting 17 kDa from the C-terminal segment would produce a 34-kDa dimer with nonreducing SDS/PAGE (see Fig. 4D ). Indeed, digestion of phosphorylated and GSSGoxidized rC/EBP␤/LAP with thrombin produced a 34-kDa band that was not observed in unphosphorylated rC/EBP␤/LAP (Fig.  4C ). This result indicates that only three cysteinyl-SHs (see Fig.  4D Lower) could have given rise to the S-S cross-links in the full-length native molecule that produced the 34-kDa dimer.
Effect of Mutating Cysteine Residues on DNA Binding Activity. We focused our efforts on the three cysteine residues (Cys 143 , Cys 201 , and Cys 296 ) located in the C-terminal segment after thrombin cleavage. The most obvious candidate for S-S bond formation in a dimer is C 296 because this SH group is perfectly juxtaposed next to the leucine zipper at the C terminus. Each of the three cysteines in the C-terminal segment of rC/EBP␤/LAP was mutated to serine (C 143 S, C 201 S, and C 296 S), expressed and purified along with Wt as described in Fig. 1 . To ascertain which of these cysteines is important in GSSG-induced disulfide bond formation, and thereby DNA binding activity, EMSA was conducted before and after phosphorylation. The mutant and Wt rC/EBP␤/LAP proteins were equally phosphorylated by MAPK and GSK3␤ (Fig. 5A) . When subjected to oxidation with GSSG, the dimerized rC/EBP␤/LAPs were still observed on the nonreducing SDS/PAGE presumably because of disulfide bond formation through the remaining cysteine residues (data not shown). However, the DNA binding activity was markedly reduced by the C 143 S and C 296 S mutations (Fig. 5A) , indicating that the cysteine residues that bracket the DNA binding domain are responsible for the oxidation-induced increase of DNA binding activity. This assertion was verified by the finding that the double Cys 143/296 mutant exhibited even lower DNA binding activity after dual phosphorylation and GSSG-induced oxidation (Fig. 5B) . Taken together, these findings indicate that phosphorylation of rC/EBP␤/LAP by MAPK and GSK3␤ produces a conformational change that favors dimerization. Although it is not known whether disulfide bond formation occurs in intact cells and is required for DNA binding in vivo, oxidation of rC/EBP␤/LAP in vitro, together with dual phosphorylation, promotes even stronger DNA binding.
Model.
A model (shown in Fig. 6 ) is proposed that accounts for the experimental results presented here and previously (6) . We visualize that C/EBP␤/LAP is phosphorylated by MAPK immediately (Յ2 h) after induction of differentiation, followed much later (Ϸ14 h) by phosphorylation by GSK3␤ at which point a conformational change occurs that renders the leucine zipper of monomeric C/EBP␤/LAP accessible for dimerization. Dimerization would be expected to bring together the basic regions of the two monomers to create a ''scissors-like'' DNA binding pocket just above the coiled-coil leucine zipper (Fig. 6) as proposed by McKnight (16) . The effect of dimerization on DNA binding is supported by the fact that mild oxidation by GSSG creates a disulfide-linked dimer, which, when disrupted by mutation of Cys 143 and Cys 296 (Fig. 5B) , markedly decreases DNA binding (Fig. 6 ). In the cell where disulfide links would not be expected because of a reducing environment, C/EBP␤/LAP would exist in a monomer-dimer equilibrium that would be shifted to ''active'' dimer by dual phosphorylation. It should be noted that under reducing conditions in vitro [i.e., in the presence of 1 mM dithiothreitol (DTT)], despite the disruption of disulfide bond formation, DNA binding occurs but only after dual phosphorylation (Fig. 2 A) . The monomer-dimer equilibrium Fig. 6 . Effect of phosphorylation-and dimerization-induced conformational changes on the DNA binding activity of C/EBP␤/LAP. Visualized are the effects of (i) the phosphorylation by MAPK and GSK3␤ on the conformation and dimerization of C/EBP␤/LAP monomer, and (ii) the GSSG-induced Cysoxidation/dimerization on the monomer-dimer equilibrium of doubly phosphorylated C/EBP␤/LAP. The size of the DNA symbol is intended to indicate the tightness of DNA binding.
